National Association of Testing Authorities, Australia
Scope of Accreditation
Australian Clinical Labs
Site
Adelaide Airport Laboratory
Accreditation No.
3427
Site No.
24606
Date of Accreditation
10 Dec 2018
Contact
Mrs Natalie Taylor P: +61 (08) 82055683
Availability
Services available to external clients
Supervision
GY (General)
Scope of Accreditation
Anatomical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
05 Sep 2026
Last Activity Date
09 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Sputum; Urine | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
Chemical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
05 Sep 2026
Last Activity Date
09 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Digoxin; Lithium; Valproate (valproic acid, epilim) |
| Serum | Carbamazepine | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); Prostate specific antigen (PSA) fractions and derived index; α-Fetoprotein (AFP) |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | Aldosterone; Renin |
| Cortisol; Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone | ||
| Urine | Cortisol | |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | Troponin I |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Alkaline phosphatase (ALP) isoenzymes |
| Caeruloplasmin; α1-Antitrypsin | ||
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Plasma; Serum | Haptoglobins |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Plasma; Serum; Urine | Osmolality |
| Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Corrected for albumin; Calcium - Total; Chloride; Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; HDL - Quantitation; Lactate dehydrogenase (LDH); Lipase; Magnesium; Osmolality; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | ||
| Urine | Calcium - Total; Chloride; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for folate deficiency | Blood; Plasma; Serum | Folate; Red blood cell folate |
| Chemical pathology - Iron studies | Blood; Plasma; Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of vitamins | Blood; Plasma; Serum | Cobalamin (vitamin B12); Vitamin D |
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Rheumatoid factor |
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin |
| Plasma; Serum; Urine | Cryofibrinogen; Cryoglobulins; Detection and amount of paraproteins; Detection and quantitation of free kappa and free lambda light chains; Free light chains | |
| Urine | Detection and amount of paraproteins | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma; Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Immunoglobulin subclasses | ||
| Total immunoglobulin E | ||
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Serum | Human chorionic gonadotropin (hCG) |
| Urine | Human chorionic gonadotropin (hCG) | |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Functional Serology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
05 Sep 2026
Last Activity Date
09 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Markers of bone metabolism | Urine | n-Telopeptide (NTx) |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
05 Sep 2026
Last Activity Date
09 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Diagnosis of thalassemia | Blood | Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Full blood examination | Blood | Morphology |
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Nucleated red blood cells (NRBC); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices; Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
| Plasma | Activated partial thromboplastin time (APTT); Anti-thrombin III; D-dimer; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Platelet function (PFA); Protein C and protein S; Prothrombin time (PT); Thrombin time (TT) | |
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence |
| Haemoglobin S (HbS) - Presence; Haemoglobin bands; Haemoglobin fraction (S, C, D, E) - Quantitation; Haemoglobin instability; Other abnormal haemoglobins | ||
| Haematology - Investigation of haemolysis | Plasma; Serum | Haptoglobins |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Erythrocyte (RBC) sedimentation rate (ESR) | ||
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Infectious mononucleosis |
Immunopathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
05 Sep 2026
Last Activity Date
09 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma | Anti-cyclic citrullinated peptide antibodies (CCP); Anti-thyroglobulin antibodies (Tg) |
Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
05 Sep 2026
Last Activity Date
09 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Chemical pathology - Investigation of Helicobacter pylori colonisation or eradication | Breath | C14 |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis for post vasectomy and/or examination of cervical mucus | Semen | Presence of spermatozoa |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Blood | Bacteria |
| Respiratory specimens; Sputum; Throat swabs; Wound swabs | Bacteria | |
| Pathogenic identification and antibiotic susceptibility | ||
| Pathogenic identification and antibiotic susceptibility | ||
| Urine | Bacteria | |
| Pathogenic identification and antibiotic susceptibility | ||
| Bilirubin; Glucose; Ketones; Nitrite; Proteins; Specific gravity; Urobilinogen; pH | ||
| Casts; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Pathogenic identification and antibiotic susceptibility | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Anal swab; Endocervical swabs; Rectal swabs; Throat swabs; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae |
| Bronchial washings; Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum | Bordetella parapertussis | |
| Dry swabs; Genital swabs; Nasal swabs | Bordetella parapertussis; Bordetella pertussis; Streptococcus agalactiae (Streptococcus group B); Methicillin resistant Staphylococcus aureus (MRSA); Methicillin susceptible Staphylococcus aureus (MSSA) | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Bronchial washings; Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) |
| Nasal aspirates/washes; Nasal swabs; Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Aspirates; Blood; Cerebrospinal fluid (CSF); Faeces; General swabs; Skin swabs; Sputum; Tissues; Urine; Wound swabs | Mycobacteria identification; Other pathogenic bacteria to genus level or species level |
| Aspirates; Blood; Cerebrospinal fluid (CSF); Faeces; Sputum; Tissues; Urine | Mycobacteria identification | |
| Blood; Cerebrospinal fluid (CSF); Other body fluids; Sputum; Tissues | Mycobacteria antibiotic susceptibility; Mycobacteria identification | |
| Microbiology - Mycobacteriology - Tests for cell mediated immunity | Blood | Latent tuberculosis |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Nails; Serum; Skin; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Aspirates; Blood; Cerebrospinal fluid (CSF); General swabs; Nails; Sputum; Tissues; Urine | Fungi identification |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Faeces | Cryptosporidia; Giardia spp.; Cysts; Ova; Parasites | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Cytomegalovirus (CMV) IgG avidity; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus surface antigen (HBs Ag) - Confirmatory; Hepatitis C virus (HCV); Rubella IgM antibody; Toxoplasma gondii IgM antibody |
| Human T-lymphotropic virus type I/II (HTLV-I/II) antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Fluorescent Treponemal antibody | ||
| Streptococcal anti-DNAse B (anti-streptodornase) antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Legionella pneumophila total antibody | ||
| Chlamydia spp.; Chlamydia trachomatis; Chlamydial pneumoniae IgG antibody | ||
| Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Epstein-Barr virus IgM antibody; Epstein-Barr virus nuclear antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgG antibody | ||
| Coxiella burnetii (Q-fever) IgM phase 2 antibody | ||
| Chlamydia trachomatis; Chlamydial pneumoniae IgG antibody | ||
| Coxiella burnetii (Q-fever) IgG phase 2 antibody | ||
| Leptospira IgM antibody | ||
| Anti-streptolysin O (ASOT) | ||
| Chlamydial pneumoniae IgG antibody; Chlamydial spp. IgG antibody; Chlamydial spp. IgM antibody; Chlamydial group IgA antibody | ||
| Serum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis A virus antibody (anti-HAV) - Total; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus antibody (anti-HCV); Hepatitis C virus antibody (anti-HCV) - IgG; Human immunodeficiency virus (HIV); Rubella IgG antibody; Rubella IgM antibody; Syphilis Treponema pallidum antibody; Toxoplasma gondii IgG antibody; Toxoplasma gondii IgM antibody; Toxoplasma |
Toxicology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
05 Sep 2026
Last Activity Date
09 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Urine | Alcohol; Amphetamines; Barbiturates; Benzodiazepines; Buprenorphine; Cannabis; Cocaine; Methadone; Opiates; Oxycodone |
ISO 15189 (2022)
Legal
Medicare expiry date
05 Sep 2026
Last Activity Date
09 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS/NZS 4308:2008, appendix A On-site screening procedure - Testing performed at client sites | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Opiates |
| Medico legal drug testing AS/NZS 4308:2008, appendix A On-site screening procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Opiates |
| Medico legal drug testing AS/NZS 4308:2008, section 2 Specimen collection, storage, handling and dispatch | Urine | Colour; Creatinine; Temperature; pH |
| Medico legal drug testing AS/NZS 4308:2008, section 3 General laboratory requirements | Urine | General laboratory requirements as described in AS/NZS 4308 |
| Medico legal drug testing AS/NZS 4308:2008, section 4 Laboratory screening procedures | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Opiates |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
3427
Site No.
24606
Print date
08 Dec 2024
END OF SCOPE